At a recent conference, I met one of Canada’s most inspiring female entrepreneurs, Andrea Bielecki. Her story of growing and selling INVIVO, a medical communications company, is not widely known, yet it was groundbreaking in Canada for its significance within the sector, its pioneering innovation, its culture of women leaders, and its ambitious growth trajectory.
Andrea accomplished what many only dream of: selling the company she built over two decades to a large global buyer, Red Nucleus, in 2020. Her story is one of self-belief, big dreams, tragedy, and barrier-breaking. It is also a story about creating pathways for women to lead and to build meaningful impact. Women’s leadership remains deeply important to Andrea. She speaks passionately about the need to prioritize young women’s confidence, sense of purpose, and mental well-being, and believes schools must play a more active role in cultivating these qualities. At a time when artificial intelligence is poised to fundamentally disrupt education, Andrea is focused on elevating the importance of young women’s uniquely human skills, including judgment, ethics, and creativity.
The story of INVIVO began in 2000, when Andrea, then a 22-year-old science graduate from the University of Guelph, joined a small startup division of a sports marketing firm. At the time, she viewed the role as a bridge with the goal of entering medical school and becoming a physician.
Fate, however, had other plans. Andrea quickly recognized an opportunity at the intersection of technology and scientific communications. Early on, she identified a gap in the marketplace, seeing that advances in digital animation could be directly applied to the life sciences. Emerging digital tools, she realized, had the power to translate complex science into something visual, accessible, and compelling. “I realized I could help save lives by helping scientists communicate,” she explains. “Digital storytelling transformed science from something you read into something you experience.”
During these early years, Andrea experienced the tragic loss of a loved one, an event that profoundly reshaped her perspective on life, risk, and ambition. In the wake of that loss, she gained clarity around her priorities and her willingness to take bold professional risks. She borrowed money to buy into the company and eventually become its largest shareholder, while doubling down on strategic growth in areas she saw as opportunities. “After my partner died,” Andrea reflects, “my relationship with risk completely changed. Once you’ve lost that much, professional risk feels very different. I thought, worst-case scenario, I’ve owned a company and gone bankrupt before 30. Compared to what I’d already been through, that didn’t feel scary.” She also became intentional about building a workplace grounded in meaning and enjoyment, often saying that if people were not having fun, they should not come to work.
Andrea’s early team included a medical animator and a medical photographer and a programmer. Over the next 20 years, the company grew to 150 employees, 67 percent of whom were women. Yet in those early days, Andrea was often the only woman in the room with prospective clients. “Sometimes I was asked to get coffee or take coats,” she recalls. “Then my team would look to me for the final word, and the room would shift.”
Beyond gender, Andrea faced additional challenges related to her age and the unproven nature of the technology. “I knew I was coming in at a disadvantage,” she says. “So I prepared harder, learned the science, learned the technology, and earned trust by delivering.” That approach led to a series of industry firsts, including pioneering virtual reality for immersive learning, developing gaming-based education, securing Canada’s first Apple app developer license for pharmaceutical clients, and becoming an early Microsoft HoloLens partner.
It is little wonder that INVIVO attracted acquisition interest and was ultimately purchased in late 2020. At 42, Andrea exited after two decades of building a company that helped reshape how medical science is communicated. As significant as the sale was, Andrea is clear that her greatest source of pride lies not in the technology but in the people. “Selling the company wasn’t just validation of the business,” she says. “It was validation of the culture we built and the risks we took together. It’s the leaders we grew, especially the women who have gone on to shape healthcare globally.”
When told that her achievements set a high bar for young women, Andrea responds with humility and perspective. She encourages young people, including her two academically driven daughters, not to replicate her career but to find their own path. “There was luck and timing involved,” she says. “What matters is that they find what’s right for them.”